Clinical efficacy of Qiliqiangxin capsule combined with recombinant human brain natriuretic peptidein the treatment of patients with heart failure and its influence on cardiac function
芪苈强心胶囊联合重组人脑利钠肽治疗心力衰竭患者的临床疗效及其对心功能的影响

摘要

目的 分析心力衰竭患者运用芪苈强心胶囊联合重组人脑利钠肽治疗的临床疗效以及对其心功能的影响。方法 随机筛选在我医院接受治疗的心力衰竭患者30例，运用随机数字表法分为观察组与对照组各有15例，对照组行重组人脑利钠肽治疗，观察组添加芪苈强心胶囊，对比两组治疗效果。结果 治疗后，观察组患者的心功能改善效果明显优于对照组，患者的6分钟步行能力明显高于对照组，并发症发生率低于对照组，患者取得的治疗总有效率高于对照组，最终患者的生活活动能力和生活质量与对照组相比显著提高，（P＜0.05）。结论 对心力衰竭患者及时开展芪苈强心胶囊联合重组人脑利钠肽治疗方案进行治疗，可使临床治疗效果得到进一步提升，减轻患者的心功能损伤程度，提高患者的生活活动能力以及生活质量。

Abstract

Objective To analyze the clinical effect of Qiliqiangxin capsule combined with recombinant human brain natriuretic peptide and its effect on its cardiac function.
Methods 30 patients with heart failure treated in our hospital were randomly selected, and 15 cases were divided into observation group and control group with recombinant human brain natriuretic peptide, and the observation group added Qiliqiangxin capsule to compare the treatment effect of the two groups.
Results After treatment, the improvement effect of cardiac function in the observation group was significantly better than that of the control group, the 6-minute walking ability was significantly higher than that of the control group, the complication rate was lower than that of the control group, the total response rate of the patients was higher than that of the control group, and the life activity and quality of life were significantly improved compared with that of the control group (P <0.05).
Conclusion   The timely treatment of Qiliqiangxin capsule combined with recombinant human brain natriuretic peptide for patients with heart failure can further improve the clinical treatment effect, reduce the degree of cardiac function damage of patients, and improve the life activity ability and quality of life of patients.